Tomoyuki Yuasa

697 total citations
28 papers, 544 citations indexed

About

Tomoyuki Yuasa is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Tomoyuki Yuasa has authored 28 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Surgery and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Tomoyuki Yuasa's work include Metabolism, Diabetes, and Cancer (10 papers), Pancreatic function and diabetes (8 papers) and Chronic Kidney Disease and Diabetes (5 papers). Tomoyuki Yuasa is often cited by papers focused on Metabolism, Diabetes, and Cancer (10 papers), Pancreatic function and diabetes (8 papers) and Chronic Kidney Disease and Diabetes (5 papers). Tomoyuki Yuasa collaborates with scholars based in Japan, Australia and United States. Tomoyuki Yuasa's co-authors include Yousuke Ebina, Cordula Hohnen-Behrens, Kyle L. Hoehn, David E. James, Anna Cederberg, Nigel Turner, Lindsay E. Wu, Kazuhiro Kishi, Hideki Hayashi and Asako Minami and has published in prestigious journals such as Neurology, Cell Metabolism and Diabetes.

In The Last Decade

Tomoyuki Yuasa

25 papers receiving 535 citations

Peers

Countries citing papers authored by Tomoyuki Yuasa

Since Specialization

Citations

This map shows the geographic impact of Tomoyuki Yuasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Yuasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Yuasa more than expected).

Fields of papers citing papers by Tomoyuki Yuasa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Yuasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Yuasa. The network helps show where Tomoyuki Yuasa may publish in the future.

Co-authorship network of co-authors of Tomoyuki Yuasa

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Yuasa. A scholar is included among the top collaborators of Tomoyuki Yuasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Yuasa. Tomoyuki Yuasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative effects of Imeglimin and empagliflozin on the redox-inflammation-organ stress axis in type 2 diabetes: a randomized controlled trial 2025 ·Toshiki Otoda, (unknown), (unknown), (unknown), (unknown), Motoyuki Tamaki, (unknown), Tomoyuki Yuasa, Tadateru Takayama, Munehide Matsuhisa, Ken‐ichi Aihara	1
2	Red blood cell distribution width is associated with renal tubular injury in individuals with type 2 diabetes 2025 ·Journal of Diabetes Investigation ·(unknown), (unknown), (unknown), Yuki Yamaguchi, (unknown), (unknown), (unknown), (unknown), Toshiki Otoda, Tomoyuki Yuasa, (unknown), Takeshi Harada, Hirokazu Miki, (unknown), (unknown), Munehide Matsuhisa, Ken‐ichi Matsuoka, Ken‐ichi Aihara	0
3	Development of Liver Fibrosis Represented by the Fibrosis-4 Index Is a Specific Risk Factor for Tubular Injury in Individuals with Type 2 Diabetes 2024 ·Biomedicines ·(unknown), Takeshi Watanabe, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kiyoe Kurahashi, Toshiki Otoda, Tomoyuki Yuasa, (unknown), Itsuro Endo, (unknown), Akira Kondo, Munehide Matsuhisa, Ken‐ichi Aihara	2
4	Humoral immune response against SARS-CoV-2 and polyethylene glycol elicited by anti-SARS-CoV-2 mRNA vaccine, and effect of pre-existing anti-polyethylene glycol antibody in patients with hematological and autoimmune diseases 2024 ·Heliyon ·(unknown), Taro Shimizu, Hidenori Ando, Naoto Okada, (unknown), (unknown), (unknown), (unknown), Toshiki Otoda, Tomoyuki Yuasa, Ken‐ichi Aihara, Makoto Takishita, (unknown), Masahiro Abe, Tatsuhiro Ishida, Shingen Nakamura	2
5	Phase angle and extracellular water-to-total body water ratio estimated by bioelectrical impedance analysis are associated with levels of hemoglobin and hematocrit in patients with diabetes 2023 ·Heliyon ·(unknown), Shingen Nakamura, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kiyoe Kurahashi, (unknown), Takeshi Harada, Akio Kuroda, Toshiki Otoda, Tomoyuki Yuasa, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe, Ken‐ichi Aihara	14
6	Albuminuria and Serum Tumor Necrosis Factor Receptor Levels in Patients with Type 2 Diabetes on SGLT2 Inhibitors: A Prospective Study 2023 ·Diabetes Therapy ·Toshiki Otoda, (unknown), (unknown), (unknown), (unknown), Motoyuki Tamaki, Tomoyuki Yuasa, (unknown), Munehide Matsuhisa, Ken‐ichi Aihara	5
7	Vascular Endothelial Function Is Associated with eGFR Slope in Female and Non-Smoking Male Individuals with Cardiovascular Risk Factors: A Pilot Study on the Predictive Value of FMD for Renal Prognosis 2023 ·Journal of Atherosclerosis and Thrombosis ·(unknown), (unknown), (unknown), (unknown), Kiyoe Kurahashi, Sumiko Yoshida, Takeshi Harada, Toshiki Otoda, Tomoyuki Yuasa, (unknown), (unknown), (unknown), (unknown), Munehide Matsuhisa, Masahiro Abe, Ken‐ichi Aihara	0
8	Dehydroepiandrosterone Sulfate, an Adrenal Androgen, Is Inversely Associated with Prevalence of Dynapenia in Male Individuals with Type 2 Diabetes 2023 ·Metabolites ·(unknown), (unknown), (unknown), (unknown), (unknown), Akihiro Tani, (unknown), Kiyoe Kurahashi, Takeshi Harada, Shingen Nakamura, Toshiki Otoda, Tomoyuki Yuasa, Hiroyasu Mori, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Takeshi Soeki, Ken‐ichi Aihara	1
9	Cross-Sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes 2023 ·Biomedicines ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kiyoe Kurahashi, Takeshi Harada, (unknown), Shingen Nakamura, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe, Ken‐ichi Aihara	2
10	Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes 2021 ·Journal of Diabetes Investigation ·(unknown), (unknown), (unknown), (unknown), (unknown), Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Yasumasa Ikeda, Itsuro Endo, (unknown), Katsuhiko Yoshimoto, Akira Kondo, Toshiaki Tamaki, Toshio Matsumoto, Munehide Matsuhisa, Masahiro Abe, Ken‐ichi Aihara	5
11	Sequential cleavage of insulin receptor by calpain 2 and γ-secretase impairs insulin signalling 2016 ·Diabetologia ·Tomoyuki Yuasa, (unknown), Shuhei Ishikura, Mitsuyoshi Takahara, Taka‐aki Matsuoka, Hideaki Kaneto, Akio Kuroda, Munehide Matsuhisa, Seiichi Hashida	26
12	Overexpression of insulin receptor partially improves obese and diabetic phenotypes in <i>db/db</i> mice 2015 ·Endocrine Journal ·Tsutomu Sasaki, (unknown), (unknown), Sho Matsui, Osamu Kikuchi, (unknown), Masaki Kobayashi, Yoshinori Tanaka, Tomoyuki Yuasa, Tadahiro Kitamura	14
13	Development of in vitro model of insulin receptor cleavage induced by high glucose in HepG2 cells 2014 ·Biochemical and Biophysical Research Communications ·Tomoyuki Yuasa, Kikuko Amo, Shuhei Ishikura, Hisao Nagaya, Keiji Uchiyama, Seiichi Hashida, Yousuke Ebina	12
14	Swirl-Flow Membrane Emulsification for High Throughput of Dispersed Phase Flux through Shirasu Porous Glass (SPG) Membrane 2010 ·JOURNAL OF CHEMICAL ENGINEERING OF JAPAN ·Mitsuya Shimoda, (unknown), Kei Nishiyama, Tomoyuki Yuasa, Seiji Noma, Noriyuki Igura	15
15	The Rab GTPase-Activating Protein AS160 as a Common Regulator of Insulin- and G.ALPHA.q-Mediated Intracellular GLUT4 Vesicle Distribution 2009 ·Endocrine Journal ·Tomoyuki Yuasa, Keiji Uchiyama, (unknown), Masafumi Kimura, Kiyoshi Teshigawara, Toshio Hosaka, Yoshinori Tanaka, Toshiyuki Obata, Hiroyuki Sano, Kazuhiro Kishi, Yousuke Ebina	13
16	IRS1-Independent Defects Define Major Nodes of Insulin Resistance 2008 ·Cell Metabolism ·Kyle L. Hoehn, Cordula Hohnen-Behrens, Anna Cederberg, Lindsay E. Wu, Nigel Turner, Tomoyuki Yuasa, Yousuke Ebina, David E. James	248
17	APS-mediated Ubiquitination of the Insulin Receptor Enhances its Internalization, but does not Induce its Degradation 2007 ·Endocrine Journal ·Kazuhiro Kishi, Kazuaki Mawatari, (unknown), Tomoyuki Yuasa, Miao Wang, (unknown), Yutaka Nakaya, Shigetsugu Hatakeyama, Yousuke Ebina	15
18	Ultracompact optical zoom lens for mobile phone 2007 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·(unknown), (unknown), Ryuichi Yoshida, Tomoyuki Yuasa, Yoshihito Souma	21
19	AMP-Activated Protein Kinase Is Activated by the Stimulations of Gq-Coupled Receptors 2000 ·Biochemical and Biophysical Research Communications ·Kazuhiro Kishi, Tomoyuki Yuasa, Asako Minami, (unknown), Akifumi Hagi, Hideki Hayashi, Bruce E. Kemp, Lee A. Witters, Yousuke Ebina	54
20	Overexpression of wild-type Akt1 promoted insulin-stimulated p70S6 kinase (p70S6K) activity and affected GSK3 beta regulation, but did not promote insulin-stimulated GLUT4 translocation or glucose transport in L6 myotubes. 2000 ·PubMed ·Shin‐ei Noda, K Kishi, Tomoyuki Yuasa, Hideki Hayashi, Tetsuo Ohnishi, (unknown), (unknown), (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact